Einloggen
Einloggen
Oder einloggen mit
GoogleGoogle
Apple Apple     
Registrieren
Oder einloggen mit
GoogleGoogle
Apple Apple     

Business Leaders

HomeAlle NachrichtenMeistgelesene ArtikelBusiness Leaders Biografien 
▄bersicht 
Founder of Centrexion Therapeutics Corp., Jeffrey B. Kindler is a businessperson who has been the head of 8 different companies and presently occupies the position of Chairman of GLG Healthcare Institute, Executive Chairman for EntityRisk, Inc., Chief Executive Officer & Director at Centrexion Therapeutics Corp., Operating Partner at ARTIS Ventures Management LP and Venture Advisor at Israel Biotech Fund.

He is also Member of The U.S.-Japan Business Council, Inc. and Principal at Paragon Pharmaceuticals Capital LLC and on the board of 10 other companies.

Jeffrey B. Kindler previously occupied the position of Chairman & Chief Executive Officer at Pfizer Inc., Chairman for vTv Therapeutics, Inc., Partner at Williams & Connolly LLP, Director at Starboard Capital Partners LLC, Trustee at The Business Roundtable, Trustee at The Business Council, Editor at The Harvard Law Review Association, Principal at Marathon Pharmaceuticals LLC, Venture Partner at Lux Capital Group LLC, Executive VP-Corporate Relations & General Counsel at McDonald's Corp. and President of Partner Brands (a subsidiary of McDonald's Corp.), Vice President-Litigation & Legal Policy at General Electric Co., Chairman at Boston Market Corp., Chairman of Pharmaceutical Research & Manufacturers of America, Trustee at Ronald McDonald House Charities Central West, Director at Lincoln Center for the Performing Arts, Inc. and Director at Manhattan Theatre Club, Inc.

He received an undergraduate degree from Tufts University and a graduate degree from Harvard Law School.


Aktuelle Stellungen und Verantwortungsbereiche Jeffrey B. Kindler 
NameTitel Seit
Perrigo Company plc
(Pharmazeutika)
Independent Director 2017
Terns Pharmaceuticals, Inc.
(Biotechnologie)
Independent Director 2020
Precigen, Inc.
(Pharmazeutika)
Independent Director 2011
Centrexion Therapeutics Corporation
(Biotechnologie)
Chief Executive Officer & Director 2013
EntityRisk, Inc. Executive Chairman -
GLG Healthcare Institute Chairman -
The John F. Kennedy Center for the Performing Arts Trustee -
The Council on Competitiveness Trustee -
Jazz At Lincoln Center, Inc. Director -
Tufts University Trustee -
Vium, Inc. Director -
Biotechnology Innovation Organization Director -
Pharmaceutical Product Development LLC Director -
The U.S.-Japan Business Council, Inc. Member -
Paragon Pharmaceuticals Capital LLC Principal -
ARTIS Ventures Management LP Operating Partner 2020
Israel Biotech Fund Venture Advisor 2015


Anteile an Jeffrey B. Kindler 
NameAktien%Wert
Perrigo Company plc (PRGO)
(Pharmazeutika)
18 4500,014%509 958 USD
Precigen, Inc. (PGEN)
(Pharmazeutika)
334 9610,13%378 506 USD
Terns Pharmaceuticals, Inc. (TERN)
(Biotechnologie)
00,0000%0 USD


Jeffrey B. Kindler: Pers÷nliches Netzwerk 
Meistgelesene Nachrichten 
29.11.Buffetts Berkshire verklagt den Milliardär Haslams im Streit um die Bewertung von Pilot
MR
28.11.Charlie Munger, das "Orakel von Pasadena", das Buffetts Stellvertreter war
MR
30.11.Tesla will Cybertrucks ausliefern, nachdem Musk die Erwartungen gedämpft hat
MR
22.11.LVMH-Erbe Antoine Arnault zieht sich aus dem Management von Berluti zurück
MR
24.11.BAYER IM FOKUS: Wohin steuert der Agrar- und Pharmakonzern?
DP
28.11.Berkshire Hathaway-Vizepräsident Charlie Munger stirbt im Alter von 99 Jahren
MR
22.11.Factbox-LVMH-Positionen der Kinder von Bernard Arnault
MR
26.11.Kuehne prüft Angebot für Signa-Hochhaus in Hamburg -Report
MR
30.11.BPs Suche nach einem neuen CEO wird sich bis ins nächste Jahr hinziehen, während die Looney-Untersuchung sich hinzieht
MR
28.11.Elon Musk verspricht, das Symbol der Geiseln von Gaza zu tragen
MR
Mehr B÷rsen-Nachrichten


© 2023 People and Ownership :   
Jeffrey B. Kindler : Verbindungen 


Die besten Tools - exklusiv fŘr unsere Abonnenten - um die Performance Ihrer Investitionen zu steigern!Meine Gewinne optimieren
Meine Gewinne optimieren